It really puts companies in a difficult spot. Dianne Munevar, head of Healthsperiens center for health, research, policy, and strategy, said that while telehealth companies offering prescription drugs would still fall under FDA jurisdiction, there are regulatory gray areas when these companies offer compounded medications that do not receive FDA approval. Munevar co-authored a study this year on ways to strengthen oversight of drug promotions on social media, suggesting the agency should clarify its regulatory authority under the Federal Food, Drug, and Cosmetic Act with respect to false and misleading advertising of compounded drugs
For GLP-1 Users: GLP-1 medications actively slow gastric emptying, frequently leading to stubborn constipation
The best oral GLP-1s available today deliver 11 to 14 percent weight loss
Other Treatments Semaglutide works wonders on its own, but it works even better when you pair it with treatments like body contouring
Regulatory Status: Please note that as of early 2026, Retatrutide remains an investigational compound
